Table 1.
Before nearest-neighbor propensity matching |
After nearest-neighbor propensity matching |
|||||||
---|---|---|---|---|---|---|---|---|
Total | RA hospitalizations | Non-RA hospitalizations | p-Value | Total | RA hospitalizations | Non-RA hospitalizations | p-Value | |
No of observations in the sample (n) | 5,984,453 | 93,750 | 5,890,703 | 375,000 | 93,750 | 281,250 | ||
Weighted estimate, N (%) | 29,922,246 (98.43) | 468,750 (1.57) | 29,453,496 (98.43) | 1,874,999 | 468,750 (25) | 1,406,249 (75) | ||
Sex, N (%) | 1 | |||||||
Male | 12,270,187 (41.01) | 121,965 (26.02) | 12,148,222 (41.25) | <0.0001 | 487,860 (26.02) | 121,965 (26.02) | 365,895 (26.02) | |
Female | 17,652,059 (58.99) | 346,785 (73.98) | 17,305,274 (58.75) | 1,387,139 (73.98) | 346,785 (73.98) | 1,040,354 (73.98) | ||
Age | ||||||||
Mean (se) | 67.46 (0.08) | 57.19 (0.10) | <0.0001 | 67.47 (0.06) | 67.47 (0.08) | 1 | ||
Age Category, % | <0.0001 | |||||||
18–34 | 20.07 | 3.00 | 20.34 | 3.00 | 3.00 | 3.00 | 1 | |
35–64 | 39.29 | 35.82 | 39.35 | 35.82 | 35.82 | 35.81 | ||
>65 | 40.64 | 61.19 | 40.31 | 61.19 | 61.19 | 61.19 | ||
Race, % | <0.0001 | <0.0001 | ||||||
Caucasians | 68.67 | 76 | 68.55 | 73.83 | 76 | 73.11 | ||
African American | 14.73 | 11.95 | 14.78 | 13.04 | 11.95 | 13.40 | ||
Others | 16.6 | 12.05 | 16.67 | 13.13 | 12.05 | 13.49 | ||
Charlson Comorbidity Index, % | <0.0001 | <0.0001 | ||||||
0 | 41.35 | 0.76 | 42 | 22.58 | 0.76 | 29.85 | ||
1 | 20.67 | 29.78 | 20.53 | 24.99 | 29.78 | 23.39 | ||
≥2 | 37.98 | 69.46 | 37.47 | 52.43 | 69.46 | 46.76 | ||
Smoking hx % | 26.13 | 28.88 | 26.09 | <0.0001 | 26.94 | 28.88 | 26.30 | <0.0001 |
COPD prevalence, % |
13.53 | 21.12 | 13.41 | <0.0001 | 18.72 | 21.12 | 17.92 | <0.0001 |